| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,158 | 13,694 | 13,224 | 13,254 | | Cost of Revenue |
-
| 3,466 | (10,133) | 3,307 | | | Gross Profit |
-
| 10,227 | 23,357 | 9,947 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,774 | 2,165 | 15,483 | 1,976 | | Non Recurring |
-
|
-
| 1,530 |
-
| | Others | 3,335 | 3,407 | 3,356 | 4,659 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 4,656 | 2,988 | 3,312 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 297 | 1,664 | (1,664) | | Earnings Before Interest And Taxes | 5,217 | 4,953 | 4,652 | 1,648 | | Interest Expense |
-
| 1,273 | 1,275 | 1,269 | | Income Before Tax | 3,924 | 3,681 | 3,377 | 379 | | Income Tax Expense | 1,492 | 1,417 | 1,244 | 144 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,432 | 2,264 | 2,133 | 235 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,432 | 2,264 | 2,133 | 235 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,432 | $2,264 | $2,133 | $235 |
|
0.51% Nasdaq 
Income Statement
